Company Filing History:
2 out of 3,539 
2 out of 2 Years Active: 2015-2017
Title: Hanh T Nguyen: Innovator in Hepatitis E Research
Introduction
Hanh T Nguyen is a notable inventor based in Lanham, MD (US), recognized for his significant contributions to the field of infectious diseases, particularly hepatitis E. With a total of two patents to his name, Nguyen's work has advanced the understanding and treatment of this viral infection.
Latest Patents
Nguyen's latest patents focus on the infectious hepatitis E virus genotype 3 recombinants. The invention relates to the discovery of an HEV strain from a chronically infected patient. This strain grows unusually well in numerous cell cultures, leading to the development of cell cultures, vectors, and vaccine compositions based on the virus. The invention also highlights the identification of a new strain of HEV genotype 3 virus, known as Strain Kernow-C1, which was isolated from a chronically infected patient. This strain was instrumental in identifying human, pig, and deer cell lines that are permissive for infection. Furthermore, the adaptation of the Kernow-C1 strain to growth in human hepatoma cells resulted in a rare virus recombinant that contains an insertion of 174 ribonucleotides (58 amino acids) of a human ribosomal protein gene along with additional mutations.
Career Highlights
Throughout his career, Hanh T Nguyen has worked with prestigious organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services, and the Royal Cornwall Hospital Trust. His research has been pivotal in the field of virology, particularly in understanding hepatitis E.
Collaborations
Nguyen has collaborated with esteemed colleagues such as Suzanne U Emerson and Priyanka Shukla, contributing to the advancement of research in infectious diseases.
Conclusion
Hanh T Nguyen's innovative work in hepatitis E research has led to significant advancements in the understanding and potential treatment of this viral infection. His contributions continue to impact the field of virology and public health.